Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1928 1
1929 1
1932 1
1939 1
1945 1
1946 4
1947 1
1948 1
1950 1
1951 1
1952 5
1953 5
1954 3
1955 1
1956 3
1957 1
1958 6
1959 1
1960 4
1961 5
1962 5
1963 7
1964 11
1965 12
1966 8
1967 8
1968 13
1969 11
1970 12
1971 18
1972 23
1973 15
1974 14
1975 26
1976 20
1977 21
1978 21
1979 26
1980 35
1981 44
1982 40
1983 44
1984 46
1985 52
1986 59
1987 65
1988 65
1989 71
1990 79
1991 61
1992 77
1993 75
1994 93
1995 91
1996 96
1997 91
1998 79
1999 96
2000 108
2001 80
2002 97
2003 91
2004 115
2005 94
2006 128
2007 130
2008 149
2009 155
2010 179
2011 237
2012 254
2013 255
2014 282
2015 269
2016 306
2017 245
2018 247
2019 225
2020 245
2021 298
2022 254
2023 246
2024 229
2025 240

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,198 results

Results by year

Filters applied: . Clear all
Page 1
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.
McCormack M, Eminowicz G, Gallardo D, Diez P, Farrelly L, Kent C, Hudson E, Panades M, Mathew T, Anand A, Persic M, Forrest J, Bhana R, Reed N, Drake A, Adusumalli M, Mukhopadhyay A, King M, Whitmarsh K, McGrane J, Colombo N, Mak C, Mandal R, Chowdhury RR, Alamilla-Garcia G, Chávez-Blanco A, Stobart H, Feeney A, Vaja S, Hacker AM, Hackshaw A, Ledermann JA; INTERLACE investigators. McCormack M, et al. Among authors: king m. Lancet. 2024 Oct 19;404(10462):1525-1535. doi: 10.1016/S0140-6736(24)01438-7. Epub 2024 Oct 14. Lancet. 2024. PMID: 39419054 Free article. Clinical Trial.
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.
Cheng HH, Shevach JW, Castro E, Couch FJ, Domchek SM, Eeles RA, Giri VN, Hall MJ, King MC, Lin DW, Loeb S, Morgan TM, Offit K, Pritchard CC, Schaeffer EM, Szymaniak BM, Vassy JL, Katona BW, Maxwell KN. Cheng HH, et al. Among authors: king mc. JAMA Oncol. 2024 Sep 1;10(9):1272-1281. doi: 10.1001/jamaoncol.2024.2185. JAMA Oncol. 2024. PMID: 39052257 Free PMC article. Review.
Regulated induced proximity targeting chimeras-RIPTACs-A heterobifunctional small molecule strategy for cancer selective therapies.
Raina K, Forbes CD, Stronk R, Rappi JP Jr, Eastman KJ, Zaware N, Yu X, Li H, Bhardwaj A, Gerritz SW, Forgione M, Hundt A, King MP, Posner ZM, Correia AD, McGovern A, Puleo DE, Chenard R, Mousseau JJ, Vergara JI, Garvin E, Macaluso J, Martin M, Bassoli K, Jones K, Garcia M, Howard K, Yaggi M, Smith LM, Chen JM, Mayfield AB, De Leon CA, Hines J, Kayser-Bricker KJ, Crews CM. Raina K, et al. Among authors: king mp. Cell Chem Biol. 2024 Aug 15;31(8):1490-1502.e42. doi: 10.1016/j.chembiol.2024.07.005. Epub 2024 Aug 7. Cell Chem Biol. 2024. PMID: 39116881 Free PMC article.
Regenerative Healing.
Sefton MV, King M, King A. Sefton MV, et al. Among authors: king m. Tissue Eng Part A. 2025 Oct 23. doi: 10.1177/19373341251392179. Online ahead of print. Tissue Eng Part A. 2025. PMID: 41194632 Free article.
6,198 results